Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.
E5-CP vaccines elicited strong anti-tumor effects.
»
10/08/17
Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men.
Measured adolescent overweight and obesity are associated with increased risk of MBC.
»
05/17/17
Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
GATA3 or uroplakin II immunoreactivity can rule out a gastric primary.
»
08/09/17
miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer
miR-92b-3p knockdown induced an aggressive phenotype in PC cells.
»
10/27/17
PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival
Subcellular location of securin was found with potential prognostic value.
»
10/27/17
Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation
Downregulation of miR-143/miR-107 associates with poor patient prognosis.
»
10/26/17
Oral primary care: an analysis of its impact on the incidence and mortality rates of oral cancer
Mortality was inversely associated with the coverage of primary care teams.
»
10/30/17
Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway
Cell proliferation significantly decreased and cell apoptosis was induced.
»
10/30/17
Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling
Metabolic pathways may be associated with specific pathways such as serine-glycine-one-carbon and glutaminolytic pathways.
»
11/02/17
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
Treatment with NVP-AEW541 increased potency of lapatinib almost seven-fold.
»
11/03/17
< Prev
Next >